2012 Annual Meeting | Special Topics in the Neurology of Sleep

Date Friday 04/27/12

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Alon Y. Avidan, MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should have a greater understanding of the common sleep disorders comorbid in neurology and familiar with sleep disorders that may result from underlying neurological conditions and are directly attributable to the disorder itself or from treatment of the underlying condition.

Participants should be more confident in the assessment and management of patients who present with hypersomnia, insomnia, and abnormal nocturnal behaviors in the setting of neurological diseases.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
01:00 PM - 01:50 PM		The Intersection of Sleep and Alzheimer's Disease Jeffrey Ellenbogen, MD
01:50 PM - 02:45 PM		Hypersomnia Secondary to Neurological Disorders Raman K. Malhotra, MD, FAAN
02:45 PM - 03:00 PM		Break
03:00 PM - 03:50 PM		Insomnia Cases for the Neurologist Phyllis C. Zee, MD, PhD
03:50 PM - 04:40 PM		Clinical Pearls in the Neurology of Sleep Alon Y. Avidan, MD, MPH, FAAN
04:40 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Phyllis C. Zee, MD, PhD	Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Alon Y. Avidan, MD, MPH, FAAN	Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
Raman K. Malhotra, MD, FAAN	No disclosure on file
Jeffrey Ellenbogen, MD	No disclosure on file

��ɫ��

��ɫ��